Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine G Bielick

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Infectious Disease Clinics of North America|September 11, 2024
Cardiovascular Implantable Electronic Device Infections: A Contemporary ReviewCatherine G Bielick, Christopher J Arnold, Vivian H Chu
PLOS Digital Health|May 26, 2026
Moving beyond the benchmarks: Five foundational principles for meaningful AI evaluation in healthcareCatherine G Bielick, Aya Awwad, Jacob Ellen, et al.
Plos One|June 4, 2021
End-stage kidney disease and COVID-19 in an urban safety-net hospital in Boston, MassachusettsMohamed Hassan Kamel, Hassan Mahmoud, Aileen Zhen, et al.
The Journal of Infectious Diseases|November 20, 2020
The Effect of IL-6 Inhibitors on Mortality Among Hospitalized COVID-19 Patients: A Multicenter StudyPranay Sinha, S Reza Jafarzadeh, Sabrina A Assoumou, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 30, 2020
Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased dischargePranay Sinha, Anahita Mostaghim, Catherine G Bielick, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Infectious Disease Clinics of North America|September 11, 2024
Cardiovascular Implantable Electronic Device Infections: A Contemporary ReviewCatherine G Bielick, Christopher J Arnold, Vivian H Chu
PLOS Digital Health|May 26, 2026
Moving beyond the benchmarks: Five foundational principles for meaningful AI evaluation in healthcareCatherine G Bielick, Aya Awwad, Jacob Ellen, et al.
Plos One|June 4, 2021
End-stage kidney disease and COVID-19 in an urban safety-net hospital in Boston, MassachusettsMohamed Hassan Kamel, Hassan Mahmoud, Aileen Zhen, et al.
The Journal of Infectious Diseases|November 20, 2020
The Effect of IL-6 Inhibitors on Mortality Among Hospitalized COVID-19 Patients: A Multicenter StudyPranay Sinha, S Reza Jafarzadeh, Sabrina A Assoumou, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 30, 2020
Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased dischargePranay Sinha, Anahita Mostaghim, Catherine G Bielick, et al.
Pageof 1